Ashok Chander

Biography

As CEO of Cellanyx, Ashok is currently advancing a novel live cell biopsy-on-a-chip technology. As reported by Boston Business Journal, Urology Today and The Wall Street Journal’s Venture Wire, Cellanyx provides a first-in-class Living Cell Phenotypic cancer diagnostic platform.Ashok developed Cellanyx’s core technology during a career in academic research spanning topics from multidrug resistance to matrix-biology. A Fellow of Startup Leadership Boston, Ashok combines his background in biophysics with expertise in business spanning project management, operations, team development, entrepreneurship and raising capital.Ashok is passionate about translating basic scientific discoveries into therapeutic gains. Engaged in oncology research since 1996, Ashok is exceptionally motivated to create meaningful value for patients, physicians, payers, and investors. In collaboration with Cellanyx’s Scientific Advisory Board, Ashok has successfully initiated and currently leads four diagnostic clinical programs.Ashok enjoys collaborating with executives, clinicians, engineers, and scientists towards advancing our understanding of biological processes, promoting discovery, developing clinically actionable technologies, and creating sustainable clinical and therapeutic value.Ashok began his scientific training at NIH. Advised by two Nobel Laureates, Ashok received his S.B. in Biology from MIT and Ph.D. from Columbia University. Raised in Potomac, Maryland, Ashok is a lifelong tennis player and new father, appreciating their respective emphases on preparation, dedication, stamina, and good hands.  

Research Interest

 His research interest in Cell Biology